DarioHealth Unveils Innovative Approach to Healthcare Cost Savings at ISPOR Europe 2026
DarioHealth Introduces Innovative Research at ISPOR Europe 2026
On November 16, 2026, DarioHealth Corp. (NASDAQ: DRIO), a pioneering AI-powered healthcare technology company, unveiled its groundbreaking research at ISPOR Europe 2026 in Vienna, Austria. This international conference focuses on health economics and outcomes research, attracting industry professionals from around the globe. The presentation highlighted Dario’s unique methodology designed to estimate healthcare cost savings and return on investment (ROI) derived from biometric improvements in individuals participating in digital chronic disease management programs.
The session, led by Dr. Yifat Hershcovitz, Vice President of Clinical and Scientific Affairs at DarioHealth, was titled “Estimating Individual-Level Medical Cost Savings from Digital Chronic Disease Management: A Biometric-to-PMPM Proxy Methodology.” It provided pivotal insights into how Dario’s model effectively translates observable improvements in essential health metrics—such as blood pressure, blood glucose levels, and weight—into projected reductions in healthcare expenditures. This model meets a critical market demand for clarity and reproducibility in estimating financial benefits, particularly when access to timely medical claims data is not feasible.
Dario's innovative approach provides health plans, employers, and enterprise healthcare purchasers with essential tools to connect clinical outcomes directly to associated cost savings. By employing this method, Dario presents a practical solution that demonstrates the value of its programs in influencing purchasing decisions, contract renewals, and potential expansions into treating additional health conditions—without relying on claims data, which often requires significant time to process or is simply unavailable.
Erez Raphael, Chief Executive Officer of DarioHealth, emphasized the importance of this research, stating, "This is a powerful study that provides an evidence-based and replicable method to demonstrate the in-year cost savings that Dario delivers specific to cardiometabolic disease. Moreover, it quantifies how savings are amplified when multiple conditions are enrolled.” He underscored that this research equips Dario's clients with a validated process to verify that their investment in Dario translates into tangible cost savings.
Dr. Hershcovitz further reiterated the challenges often faced in demonstrating the economic value of digital health solutions, which frequently hinge on the availability of timely medical claims data. DarioHealth's new methodology significantly mitigates this issue by translating measurable changes in clinical parameters into transparent financial estimates. This allows healthcare purchasers to assess program effectiveness and its potential economic impact meaningfully.
DarioHealth has established itself as a leader in the AI-driven healthcare sector, offering a comprehensive platform that integrates connected devices, personalized engagement strategies, AI analytics, and provider-supported clinical care. It addresses a spectrum of chronic conditions including diabetes, weight management, hypertension, musculoskeletal, and behavioral health issues. Leveraging over 13 billion proprietary healthcare data points gathered over more than a decade, Dario's innovative technology tailors care to each individual by analyzing biometric, clinical, and behavioral data, thus facilitating timely and effective health interventions.
The implications of this research are far-reaching, as they present a significant opportunity to improve health outcomes while simultaneously lowering the costs of care. As disruption and innovation continue to shape the healthcare landscape, DarioHealth is at the forefront, committed to transforming chronic condition management through evidence-based practices.
In summary, DarioHealth’s presentation at ISPOR Europe 2026 not only showcases the company’s commitment to innovation but also addresses a crucial need within the healthcare market—a robust method for quantifying cost savings and ROI—especially in a context where traditional data sources may be lacking. By pivoting towards authentic and replicable solutions, DarioHealth is setting new benchmarks for the industry, paving the way for smarter, data-driven decision-making in healthcare.